PE-owned Brammer Bio adds three to team
Brammer Bio, which is owned by Ampersand Capital Partners, has named Doug Chambers as vice president, quality and regulatory. Previously, Chambers held quality and compliance leadership roles at Millipore Sigma and Merck Research Laboratories. Also, Brammer has hired Dana Alexander as site head for Brammer's late phase and commercial viral vector manufacturing site in Cambridge, Massachusetts and Larry Pitcher as site head for its early-clinical development and viral vector manufacturing facilities in Alachua, Florida. Brammer is a viral vector contract development and manufacturing organization for companies developing gene-modified cell therapies and in vivo gene therapies.
20 March 2018•3 mins read
